Evidence map›Paper›PMID 21113164›Full record

ArticleNature immunology2011

Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes.

Arito Yamane, Wolfgang Resch, Nan Kuo, Stefan Kuchen, Zhiyu Li, Hong-wei Sun, Davide F Robbiani, Kevin McBride, Michel C Nussenzweig, Rafael Casellas

Abstract read
In one paragraph

Article in Nature immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed, 1 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 1 synthesis or guideline pooled it, 282 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Arito YamaneGenomics & Immunity, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Wolfgang Resch
Nan Kuo
Stefan Kuchen
Zhiyu Li
Hong-wei Sun
Davide F Robbiani
Kevin McBride
Michel C Nussenzweig
Rafael Casellas
National Institute of Arthritis and Musculoskeletal and Skin Diseases · USNational Institutes of Health · USHoward Hughes Medical Institute · USNational Cancer Institute · USRockefeller University · US

Funding

RAG and AID biologyZIAAR041148 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2009 to 2025
$44.8M
Applying Bioinformatics to Research in Immune, Muscle, and Bone DiseasesZIHAR041173 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI GADINA, MASSIMO · 2009 to 2020
$11.0M
Class Switch Recombination in B LymphocytesR37AI037526 · NIAID · ROCKEFELLER UNIVERSITY · PI NUSSENZWEIG, MICHEL C · 2014 to 2023
$5.4M
SIGNALLING PATHWAYS IN AUTOIMMUNITYR01AI037526 · NIAID · ROCKEFELLER UNIVERSITY · PI NUSSENZWEIG, MICHEL C · 1994 to 2012
$5.0M
Transcription, Chromatin and DNA repairZIAAR041149 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI CASELLAS, RAFAEL C · 2009 to 2010
$2.2M
Transcription, Chromatin and DNA RepairZ01AR041149 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI CASELLAS, RAFAEL C · 2005 to 2008
$1.8M
AID biologyZ01AR041148 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI CASELLAS, RAFAEL C · 2005 to 2008
$1.8M
Howard Hughes Medical InstituteIntramural NIH HHS Z01 AR041148Intramural NIH HHS Z01 AR041149NIAID NIH HHS AI037526NIAID NIH HHS R01 AI037526NIAID NIH HHS R37 AI037526
6 · The paper itself

Abstract

The cytidine deaminase AID hypermutates immunoglobulin genes but can also target oncogenes, leading to tumorigenesis. The extent of AID's promiscuity and its predilection for immunoglobulin genes are unknown. We report here that AID interacted broadly with promoter-proximal sequences associated with stalled polymerases and chromatin-activating marks. In contrast, genomic occupancy of replication protein A (RPA), an AID cofactor, was restricted to immunoglobulin genes. The recruitment of RPA to the immunoglobulin loci was facilitated by phosphorylation of AID at Ser38 and Thr140. We propose that stalled polymerases recruit AID, thereby resulting in low frequencies of hypermutation across the B cell genome. Efficient hypermutation and switch recombination required AID phosphorylation and correlated with recruitment of RPA. Our findings provide a rationale for the oncogenic role of AID in B cell malignancy.

Indexed as

Cell Transformation, NeoplasticGenes, ImmunoglobulinAnimalsB-LymphocytesCells, CulturedChromatin Assembly and DisassemblyCytidine DeaminaseGenes, mycHigh-Throughput Nucleotide SequencingImmunoglobulin Class SwitchingInterleukin-4LipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutPromoter Regions, GeneticCytidine DeaminaseInterleukin-4LipopolysaccharidesReplication Protein A

Identifiers

PMID21113164
PMCPMC3005028
OpenAlexW2170629396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.